CURRENT STATUS OF INDICATIONS AND RESULTS OF EMERGENCY BLOOD TRANSFUSION AT BACH MAI HOSPITAL FROM 2022-2023
Main Article Content
Abstract
Objective: To evaluate the current situation of emergency blood transfusion and some results of this activity at Bach Mai Hospital. Participants and Methods: The prospective descriptive study included 352 cases receiving emergency blood transfusions in Bach Mai Hospital from October 2022 to September 2023. Results: Patients received emergency blood transfusion mainly in the age group from 45 to 74 years old (66.5%), and in male patients (77.8%). The departments with the highest indications for emergency blood transfusion were the Digestive Center, the Emergency Center and the Anesthesia and Resuscitation Center (76.8% totally). The main cause for requiring emergency blood transfusion at Bach Mai Hospital was gastrointestinal bleeding (more than 70% in total). Conclusion: Emergency blood transfusion at Bach Mai Hospital is primarily applied to middleaged men with gastrointestinal bleeding, resulting in positive treatment outcomes for the majority of cases.
Keywords
Clinical blood transfusion, emergency blood transfusion, hemorrhage
Article Details
References
2. Australian Government Department of Health. Requirements for Transfusion Laboratory Practice. 4th ed. 2019.
3. World Health Organization. Educational Modules on Clinical Use of Blood. 2021.
4. World Health Organization. The Clinical Use of Blood. 2001.
5. Goodell PP, Uhl L, Mohammed M, Powers AA. Risk of Hemolytic Transfusion Reactions Following Emergency-Release RBC Transfusion. Am J Clin Pathol. 2010;134(2):202-206.
6. Selleng K, Jenichen G, Denker K, Selleng S, Müllejans B, Greinacher A. Emergency transfusion of patients with unknown blood type with blood group O Rhesus D positive red blood cell concentrates: a prospective, single-centre, observational study. Lancet Haematol. 2017;4(5):e218-e224.
7. Peyrony O, Gamelon D, Brune R, et al. Red Blood Cell Transfusion in the Emergency Department: An Observational Cross-Sectional Multicenter Study. J Clin Med. 2021;10(11):2475.
8. Mulay SB, Jaben EA, Johnson P, Badjie K, Stubbs JR. Risks and adverse outcomes associated with emergency‐release red blood cell transfusion. Transfusion. 2013;53(7):1416-1420.
9. Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical review: Hemorrhagic shock. Crit Care. 2004;8(5):373.
10. Chambers JA, Seastedt K, Krell R, Caterson E, Levy M, Turner N. “Stop the Bleed”: A U.S. Military Installation’s Model for Implementation of a Rapid Hemorrhage Control Program. Mil Med. 2019;184(3-4):67-71.
11. Roberts I, Shakur-Still H, Afolabi A, et al. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10241):1927-1936.
12. Savage SA, Sumislawski JJ, Zarzaur BL, Dutton WP, Croce MA, Fabian TC. The new metric to define large-volume hemorrhage: Results of a prospective study of the critical administration threshold. J Trauma Acute Care Surg. 2015;78(2):224-230.